Ionis Pharmaceuticals IONS Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's total revenue?
- Ionis Pharmaceuticals (IONS) reported total revenue of $246.09M in Q1 2026.
- How has Ionis Pharmaceuticals's total revenue changed year-over-year?
- Ionis Pharmaceuticals's total revenue increased by 87.0% year-over-year, from $131.61M to $246.09M.
- What is the long-term trend for Ionis Pharmaceuticals's total revenue?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's total revenue has grown at a 3.9% compound annual growth rate (CAGR), from $810.46M to $943.71M.
- What does total revenue mean?
- The total income generated from business operations before expenses.
- How do you interpret total revenue?
- Higher revenue generally signals successful product adoption, market expansion, or effective commercialization strategies.
- How does total revenue compare across companies?
- The most fundamental metric for cross-company comparison; essential for evaluating market share and growth trajectory.